{"title":"[Recent progress of chromatographic techniques for antibody purification].","authors":"Jia-Wei Liu, Chang-Wei Tang, Yi-Ran Xia, Quan Bai","doi":"10.3724/SP.J.1123.2023.12010","DOIUrl":null,"url":null,"abstract":"<p><p>Antibody drugs are becoming increasingly popular in disease diagnosis, targeted therapy, and immunoprevention owing to their characteristics of high targeting ability, strong specificity, low toxicity, and mild side effects. The demand for antibody drugs is steadily increasing, and their production scale is expanding. Upstream cell culture technology has been greatly improved by the high-capacity production of monoclonal antibodies. However, the downstream purification of antibodies presents a bottleneck in the production process. Moreover, the purification cost of antibodies is extremely high, accounting for approximately 50%-80% of the total cost of antibody production. Chromatographic technology, given its selectivity and high separation efficiency, is the main method for antibody purification. This process usually involves three stages: antibody capture, intermediate purification, and polishing. Different chromatographic techniques, such as affinity chromatography, ion-exchange chromatography, hydrophobic interaction chromatography, mixed-mode chromatography, and temperature-responsive chromatography, are used in each stage. Affinity chromatography, mainly protein A affinity chromatography, is applied for the selective capture and purification of antibodies from raw biofluids or harvested cell culture supernatants. Other chromatographic techniques, such as ion-exchange chromatography, hydrophobic interaction chromatography, and mixed-mode chromatography, are used for intermediate purification and antibody polishing. Affinity biomimetic chromatography and hydrophobic charge-induction chromatography can produce antibodies with purities comparable with those obtained through protein A chromatography, by employing artificial chemical/short peptide ligands with good selectivity, high stability, and low cost. Temperature-responsive chromatography is a promising technique for the separation and purification of antibodies. In this technique, antibody capture and elution is controlled by simply adjusting the column temperature, which greatly eliminates the risk of antibody aggregation and inactivation under acidic elution conditions. The combination of different chromatographic methods to improve separation selectivity and achieve effective elution under mild conditions is another useful strategy to enhance the yield and quality of antibodies. This review provides an overview of recent advances in the field of antibody purification using chromatography and discusses future developments in this technology.</p>","PeriodicalId":101336,"journal":{"name":"Se pu = Chinese journal of chromatography","volume":"42 6","pages":"533-543"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11165393/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Se pu = Chinese journal of chromatography","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3724/SP.J.1123.2023.12010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Antibody drugs are becoming increasingly popular in disease diagnosis, targeted therapy, and immunoprevention owing to their characteristics of high targeting ability, strong specificity, low toxicity, and mild side effects. The demand for antibody drugs is steadily increasing, and their production scale is expanding. Upstream cell culture technology has been greatly improved by the high-capacity production of monoclonal antibodies. However, the downstream purification of antibodies presents a bottleneck in the production process. Moreover, the purification cost of antibodies is extremely high, accounting for approximately 50%-80% of the total cost of antibody production. Chromatographic technology, given its selectivity and high separation efficiency, is the main method for antibody purification. This process usually involves three stages: antibody capture, intermediate purification, and polishing. Different chromatographic techniques, such as affinity chromatography, ion-exchange chromatography, hydrophobic interaction chromatography, mixed-mode chromatography, and temperature-responsive chromatography, are used in each stage. Affinity chromatography, mainly protein A affinity chromatography, is applied for the selective capture and purification of antibodies from raw biofluids or harvested cell culture supernatants. Other chromatographic techniques, such as ion-exchange chromatography, hydrophobic interaction chromatography, and mixed-mode chromatography, are used for intermediate purification and antibody polishing. Affinity biomimetic chromatography and hydrophobic charge-induction chromatography can produce antibodies with purities comparable with those obtained through protein A chromatography, by employing artificial chemical/short peptide ligands with good selectivity, high stability, and low cost. Temperature-responsive chromatography is a promising technique for the separation and purification of antibodies. In this technique, antibody capture and elution is controlled by simply adjusting the column temperature, which greatly eliminates the risk of antibody aggregation and inactivation under acidic elution conditions. The combination of different chromatographic methods to improve separation selectivity and achieve effective elution under mild conditions is another useful strategy to enhance the yield and quality of antibodies. This review provides an overview of recent advances in the field of antibody purification using chromatography and discusses future developments in this technology.
抗体药物具有靶向性强、特异性强、毒性低、副作用小等特点,在疾病诊断、靶向治疗、免疫预防等方面越来越受到青睐。抗体药物的需求稳步增长,生产规模不断扩大。单克隆抗体的高产能极大地提高了上游细胞培养技术。然而,抗体的下游纯化是生产过程中的一个瓶颈。此外,抗体的纯化成本极高,约占抗体生产总成本的 50%-80%。色谱技术具有选择性强、分离效率高等特点,是抗体纯化的主要方法。这一过程通常包括三个阶段:抗体捕获、中间纯化和抛光。每个阶段都会用到不同的色谱技术,如亲和色谱法、离子交换色谱法、疏水相互作用色谱法、混合模式色谱法和温度响应色谱法。亲和层析,主要是蛋白 A 亲和层析,可用于从原始生物流体或收获的细胞培养上清液中选择性地捕获和纯化抗体。其他色谱技术,如离子交换色谱法、疏水相互作用色谱法和混合模式色谱法,可用于中间纯化和抗体抛光。亲和仿生色谱法和疏水电荷诱导色谱法采用选择性好、稳定性高、成本低的人工化学/短肽配体,可制备出纯度与蛋白 A 色谱法相当的抗体。温度响应色谱法是一种很有前途的抗体分离和纯化技术。在这种技术中,只需调节色谱柱的温度就能控制抗体的捕获和洗脱,大大消除了酸性洗脱条件下抗体聚集和失活的风险。结合不同的色谱方法来提高分离选择性,并在温和的条件下实现有效洗脱,是提高抗体产量和质量的另一种有效策略。本综述概述了使用色谱法纯化抗体领域的最新进展,并讨论了这项技术的未来发展。